IMCC Stock Forecast: IM Cannabis Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 24 of 100 as at 21 Nov 2026 — in the weakest quartile.
One number for the whole business
Consensus tells you what everyone already believes. The model scores IM Cannabis Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (100): Reported profit is backed by cash, and the company is not expanding recklessly.
Growth (4): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
IMCC stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on IMCC, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 31 Dec 2021 | Roth Capital | Initiates | Buy | — |
| 5 Oct 2021 | Roth Capital | Initiates | Buy | — |
| 10 June 2021 | Alliance Global Partners | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
IMCC appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
IMCC analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.0×
- Price / book
- —
- EV / EBITDA
- —
Cheaper than 99% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 16.3%
- Operating margin
- −18.9%
- Net margin
- —
Higher than 16% of US stocks
Higher than 23% of US stocks
- Return on equity
- —
- Return on assets
- −19.5%
- Dividend yield
- —
Higher than 20% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
IM Cannabis Corp. has a market value of $922K and an enterprise value of $4.4M.
Revenue in the twelve months to 31 Mar 2026: $50.9M. The latest quarter shrank 30.6% year on year.
Net income over the same four quarters: −$14.4M, a −28.3% net margin.
Free cash flow in the twelve months to 31 Mar 2026: $49K, after $18K of capital spending.
IM Cannabis Corp. spent $0.0 on dividends in the twelve months to 31 Mar 2026.
IM Cannabis Corp. employs 44 people — $1.2M of revenue per employee.
Data provided by Twelve Data
IMCC and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at IMCC’s peer groups, ranked by the model: consumer staples stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own IM Cannabis Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about IMCC
How does Ticker Nerd's model rank IMCC?
As at 21 Nov 2026, IM Cannabis Corp. ranks 24 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (100 of 100).
What is the IMCC stock forecast for 2030?
No analyst covering IM Cannabis Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IMCC are extrapolating price history, which says nothing about the business.
What does IM Cannabis Corp. do?
IM Cannabis Corp. is an international medical cannabis company focused on importing, distributing, and selling cannabis-based products for medical patients in Israel and Germany. The company offers dried flower and full-spectrum cannabis extract products under brands including IMC, BLKMT, and LOT420, with a business model centered on regulated medical markets and pharmacy-based supply chains.
About IM Cannabis Corp.
IM Cannabis Corp. is an international medical cannabis company focused on importing, distributing, and selling cannabis-based products for medical patients in Israel and Germany. The company offers dried flower and full-spectrum cannabis extract products under brands including IMC, BLKMT, and LOT420, with a business model centered on regulated medical markets and pharmacy-based supply chains. Its operations include product sourcing, quality control, and market-specific distribution across Europe and the Middle East, supporting physicians, pharmacies, and patients who rely on standardized cannabis formulations. IM Cannabis Corp. also maintains an online and retail presence tied to its medical cannabis ecosystem, reinforcing its role as a specialized supplier within the healthcare and life sciences sectors. Headquartered in Kibbutz Glil-Yam, Israel, the company remains positioned as a focused participant in the growing regulated medical cannabis market.
CEO Mr. Oren Shuster · 44 employees · Canada · https://imcannabis.com